14 May,2021 01:05 PM IST | Hyderabad | IANS
Consignment of Russian Covid-19 vaccine Sputnik V arrives in India. Photo: AFP
Dr Reddy's Laboratories on Friday announced that the first consignment of imported doses of the Sputnik V coronavirus vaccine that landed in India on May 1 received regulatory clearance from the Central Drugs Laboratory, Kasauli, on May 13.
As part of a limited pilot, the soft launch of the vaccine has commenced and the first dose of the vaccine was administered in Hyderabad on Friday.
Further consignments of imported doses are expected over the upcoming months. Subsequently, supply of the Sputnik V vaccine will commence from Indian manufacturing partners.
Also Read: India to inoculate citizens with Sputnik-V COVID-19 vaccine from next month
ALSO READ
Pune firm CA's death: Labour ministry to initiate probe
Mamata Banerjee blames Centre after visit to flood-affected areas
Kolkata rape-murder: Medical registration of RG Kar hospital's former principal
Maharashtra: PM Modi to attend 'Vishwakarma' event, lay textile park foundation
Congress party 'hand in glove' with anti-national forces, says Amit Shah
The imported doses of the vaccine are presently priced at an MRP of Rs 948 + 5% GST per dose, i.e Rs 995, with the possibility of a lower price point when local supply begins.
The Company is working closely with its six manufacturing partners in India to fulfill regulatory requirements to ensure smooth and timely supply.
Dr Reddy's will work closely with stakeholders in the Government and private sector in India to ensure the widest possible reach of the Sputnik V vaccine as part of the national inoculation effort. This is a reaffirmation of the Company's commitment to explore every avenue in the fight against the Covid-19 pandemic in India.
G.V. Prasad, Co-Chairman and Managing Director, said: "With the rising cases in India, vaccination is our most effective tool in our battle against Covid-19. Contributing to the vaccination drive in India is our biggest priority right now to help Indians be healthy and safe."
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
